Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema - a long-term analysis from a Swiss perspective

BACKGROUND: The impact on patients suffering from chronic hand eczema (CHE) is enormous, as no licensed systemic treatment option with proven efficacy for CHE is available. Alitretinoin is a novel agent which showed high clinical efficacy in patients with severe, refractory CHE. We assessed the cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Blank, Patricia R, Blank, Armin A, Szucs, Thomas D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908557/
https://www.ncbi.nlm.nih.gov/pubmed/20579358
http://dx.doi.org/10.1186/1471-5945-10-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908557/
https://www.ncbi.nlm.nih.gov/pubmed/20579358
http://dx.doi.org/10.1186/1471-5945-10-4

Ejemplares similares